Clinical and therapeutic significance of aberrant differentiation patterns in bladder cancer (Q36879168)

16 August 2017

1 reference

title

Clinical and therapeutic significance of aberrant differentiation patterns in bladder cancer (English)

1 reference

16 August 2017

Peter C Black

1

1 reference

PubMed ID

17627461

16 August 2017

Gordon A Brown

series ordinal

2

1 reference

PubMed ID

17627461

16 August 2017

Colin P N Dinney

series ordinal

3

1 reference

16 August 2017

1 July 2007

1 reference

Expert Review of Anticancer Therapy

16 August 2017

1 reference

16 August 2017

7

1 reference

16 August 2017

7

1 reference

16 August 2017

1015-1026

1 reference

16 August 2017

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

Chromosomal abnormalities in two bladder carcinomas with secondary squamous cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

Systemic chemotherapy options for metastatic bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

Squamous differentiation in primary urothelial carcinoma of the urinary tract as seen by MAC387 immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

Clinical importance of squamous metaplasia in invasive transitional cell carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

Local recurrence after radical cystectomy for invasive bladder cancer: an analysis of predictive factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

Radical cystectomy for primary neuroendocrine tumors of the bladder: the university of southern california experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

Small cell carcinoma of the urinary bladder. The Mayo Clinic experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

Analysis of treatment for small cell cancer of the bladder and report of three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

Bladder preservation in small cell carcinoma of the urinary bladder: an institutional experience and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

Novel therapies for the treatment of small-cell lung cancer: a time for cautious optimism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

Histogenesis of sarcomatoid urothelial carcinoma of the urinary bladder: evidence for a common clonal origin with divergent differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

Histologic variants of urothelial carcinoma: differential diagnosis and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

The case for early cystectomy in the treatment of nonmuscle invasive micropapillary bladder carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

Squamous cell carcinoma of the bladder: pathology, diagnosis and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

Squamous cell carcinoma of bladder. A review of 114 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

Squamous cell carcinoma of the bilharzial and non-bilharzial urinary bladder: a review of etiological features, natural history, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

Pure squamous cell carcinoma of the bladder in western countries. Report on 19 consecutive cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

Postoperative radiotherapy of carcinoma in bilharzial bladder: Improved disease free survival through improving local control

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

Surgical factors influence bladder cancer outcomes: a cooperative group report

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

Intraoperative radiation therapy first part: rationale and techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

A phase II study of gemcitabine plus cisplatin chemotherapy in advanced bilharzial bladder carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

Population based survival data on urachal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

Multimodality management of urachal carcinoma: the M. D. Anderson Cancer Center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

The use of robotically assisted surgery for treating urachal anomalies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

Urachal carcinoma: surgical and chemotherapeutic options

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.7.1015

10.1586/14737140.7.7.1015

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference

PubMed ID

17627461